Fernández-Martínez, Ana B <br/><br/>
Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.  [electronic resource] 

 -  The Prostate  May 2009 
 - 774-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0045 
<br/><br/><label>Standard No.: </label>10.1002/pros.20930  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents--pharmacology<br/>Biomarkers, Tumor--biosynthesis<br/>Cadherins--biosynthesis<br/>Cell Adhesion--drug effects<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Curcumin--pharmacology<br/>Cyclin D1--metabolism<br/>Extracellular Matrix--drug effects<br/>GPI-Linked Proteins<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 2--biosynthesis<br/>Matrix Metalloproteinase 9--biosynthesis<br/>Membrane Glycoproteins--biosynthesis<br/>Microscopy, Confocal<br/>Neoplasms, Hormone-Dependent--metabolism<br/>Prostatic Neoplasms--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Vasoactive Intestinal Peptide--metabolism